Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study

L.B. Rinde; C. Lind; B. Småbrekke; I. Njølstad; E.B. Mathiesen; T. Wilsgaard; M.‐L. Løchen; E.M. Hald; A. Vik; S.K. Brækkan; J.‐B. Hansen

doi:10.1111/jth.13329

journal article Open Access Jun 01, 2016

Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study

L.B. Rinde C. Lind B. Småbrekke I. Njølstad E.B. Mathiesen T. Wilsgaard M.‐L. Løchen E.M. Hald A. Vik S.K. Brækkan J.‐B. Hansen

Journal of Thrombosis and Haemostasis Vol. 14 No. 6 pp. 1183-1191 · Elsevier BV

View at Publisher Save 10.1111/jth.13329

Topics

No keywords indexed for this article. Browse by subject →

References

41

[1]

Mackman "Triggers, targets and treatments for thrombosis" Nature (2008) 10.1038/nature06797

[2]

Prandoni "An association between atherosclerosis and venous thrombosis" N Engl J Med (2003) 10.1056/nejmoa022157

[3]

Lind "Impact of incident venous thromboembolism on risk of arterial thrombotic diseases" Circulation (2014) 10.1161/circulationaha.113.004168

[4]

Eliasson "Incidence and risk of venous thromboembolism in patients with verified arterial thrombosis: a population study based on 23 796 consecutive autopsies" J Thromb Haemost (2006) 10.1111/j.1538-7836.2006.02152.x

[5]

Lijfering "Relationship between venous and arterial thrombosis: a review of the literature from a causal perspective" Semin Thromb Hemost (2011) 10.1055/s-0031-1297367

[6]

Braekkan "Family history of myocardial infarction is an independent risk factor for venous thromboembolism: the Tromso study" J Thromb Haemost (2008) 10.1111/j.1538-7836.2008.03102.x

[7]

Lind "Family history of myocardial infarction and cause‐specific risk of myocardial infarction and venous thromboembolism: the Tromso Study" Circ Cardiovasc Genet (2014) 10.1161/circgenetics.114.000621

[8]

Quist‐Paulsen "Arterial cardiovascular risk factors and venous thrombosis: results from a population‐based, prospective study (the HUNT 2)" Haematologica (2010) 10.3324/haematol.2009.011866

[9]

Braekkan "Competing risk of atherosclerotic risk factors for arterial and venous thrombosis in a general population: the Tromso study" Arterioscler Thromb Vasc Biol (2012) 10.1161/atvbaha.111.237545

[10]

Reich "Prospective study of subclinical atherosclerosis as a risk factor for venous thromboembolism" J Thromb Haemost (2006) 10.1111/j.1538-7836.2006.02121.x

[11]

van der Hagen "Subclinical atherosclerosis and the risk of future venous thrombosis in the Cardiovascular Health Study" J Thromb Haemost (2006) 10.1111/j.1538-7836.2006.02096.x

[12]

Hald "Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study" Arterioscler Thromb Vasc Biol (2014) 10.1161/atvbaha.113.302162

[13]

Sorensen "Arterial cardiovascular events, statins, low‐dose aspirin and subsequent risk of venous thromboembolism: a population‐based case–control study" J Thromb Haemost (2009) 10.1111/j.1538-7836.2009.03279.x

[14]

Sorensen "Heart disease may be a risk factor for pulmonary embolism without peripheral deep venous thrombosis" Circulation (2011) 10.1161/circulationaha.111.025627

[15]

Severinsen "Venous thromboembolism discharge diagnoses in the Danish National Patient Registry should be used with caution" J Clin Epidemiol (2010) 10.1016/j.jclinepi.2009.03.018

[16]

Cohort profile: The Tromso Study

B. K. Jacobsen, A. E. Eggen, E. B. Mathiesen et al.

International Journal of Epidemiology 2012 10.1093/ije/dyr049

[17]

The Norwegian Institute of Public Health. Overweight and obesity in Norway: fact sheet. http://www.fhi.no/eway/default.aspx?pid=240&trg=List_6673&Main_6664=6894:0:25,7585:1:0:0:::0:0&MainContent_6894=6671:0:25,7612:1:0:0:::0:0&List_6673=6674:0:25,7616:1:0:0:::0:0. Accessed 26 February 2015.

[18]

WHO MONICA Project. MONICA Manual. http://www.thl.fi/publications/monica/index.html. Accessed 26 February 2015.

[19]

Braekkan "Body height and risk of venous thromboembolism: the Tromso Study" Am J Epidemiol (2010) 10.1093/aje/kwq066

[20]

Collins "Clinical effects of anticoagulant therapy in suspected acute myocardial infarction: systematic overview of randomised trials" BMJ (1996) 10.1136/bmj.313.7058.652

[21]

Prandoni "Prevalence of heart diseases in patients with pulmonary embolism with and without peripheral venous thrombosis: findings from a cross‐sectional survey" Eur J Intern Med (2009) 10.1016/j.ejim.2009.06.001

[22]

Ye "Seven haemostatic gene polymorphisms in coronary disease: meta‐analysis of 66,155 cases and 91,307 controls" Lancet (2006) 10.1016/s0140-6736(06)68263-9

[23]

Mahmoodi "Hereditary deficiency of protein C or protein S confers increased risk of arterial thromboembolic events at a young age: results from a large family cohort study" Circulation (2008) 10.1161/circulationaha.108.780759

[24]

Doggen "Levels of intrinsic coagulation factors and the risk of myocardial infarction among men: opposite and synergistic effects of factors XI and XII" Blood (2006) 10.1182/blood-2005-12-023697

[25]

Bank "Elevated levels of FVIII:C within families are associated with an increased risk for venous and arterial thrombosis" J Thromb Haemost (2005) 10.1111/j.1538-7836.2004.01033.x

[26]

Heit "Risk factors for deep vein thrombosis and pulmonary embolism: a population‐based case–control study" Arch Intern Med (2000) 10.1001/archinte.160.6.809

[27]

Barsoum "Are myocardial infarction and venous thromboembolism associated? Population‐based case–control and cohort studies" Thromb Res (2014) 10.1016/j.thromres.2014.06.033

[28]

Pfeffer "Ventricular remodeling after myocardial infarction. Experimental observations and clinical implications" Circulation (1990) 10.1161/01.cir.81.4.1161

[29]

Lip "Does heart failure confer a hypercoagulable state? Virchow's triad revisited" J Am Coll Cardiol (1999)

[30]

Mutin "Direct evidence of endothelial injury in acute myocardial infarction and unstable angina by demonstration of circulating endothelial cells" Blood (1999) 10.1182/blood.v93.9.2951.409k02_2951_2958

[31]

Merlini "Persistent activation of coagulation mechanism in unstable angina and myocardial infarction" Circulation (1994) 10.1161/01.cir.90.1.61

[32]

Jons "The incidence and prognostic significance of new‐onset atrial fibrillation in patients with acute myocardial infarction and left ventricular systolic dysfunction: a CARISMA substudy" Heart Rhythm (2011) 10.1016/j.hrthm.2010.09.090

[33]

Enga "Atrial fibrillation and future risk of venous thromboembolism:the Tromso study" J Thromb Haemost (2015) 10.1111/jth.12762

[34]

van Langevelde "Finding the origin of pulmonary emboli with a total‐body magnetic resonance direct thrombus imaging technique" Haematologica (2013) 10.3324/haematol.2012.069195

[35]

Hurlen "Warfarin, aspirin, or both after myocardial infarction" N Engl J Med (2002) 10.1056/nejmoa020496

[36]

van Es "Aspirin and coumadin after acute coronary syndromes (the ASPECT‐2 study): a randomised controlled trial" Lancet (2002) 10.1016/s0140-6736(02)09409-6

[37]

Alexander "Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial" Circulation (2009) 10.1161/circulationaha.108.832139

[38]

Mega "Rivaroxaban versus placebo in patients with acute coronary syndromes (ATLAS ACS‐TIMI 46): a randomised, double‐blind, phase II trial" Lancet (2009) 10.1016/s0140-6736(09)60738-8

[39]

Oldgren "Dabigatran vs. placebo in patients with acute coronary syndromes on dual antiplatelet therapy: a randomized, double‐blind, phase II trial" Eur Heart J (2011) 10.1093/eurheartj/ehr113

[40]

A Comparison of Enoxaparin with Placebo for the Prevention of Venous Thromboembolism in Acutely Ill Medical Patients

Meyer Michel Samama, Alexander Thomas Cohen, Jean-Yves Darmon et al.

New England Journal of Medicine 1999 10.1056/nejm199909093411103

[41]

Goldhaber "Apixaban versus enoxaparin for thromboprophylaxis in medically ill patients" N Engl J Med (2011) 10.1056/nejmoa1110899

Cited By

52

Plasma levels of growth differentiation factor 15 are associated with future risk of venous thromboembolism

Ellen-Sofie Hansen, Kristian Hindberg · 2020

Blood

Metrics

52

Citations

41

References

Details

Published: Jun 01, 2016
Vol/Issue: 14(6)
Pages: 1183-1191
License: View

Authors

Funding

Stiftelsen Kristian Gerhard Jebsen

Cite This Article

L.B. Rinde, C. Lind, B. Småbrekke, et al. (2016). Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study. Journal of Thrombosis and Haemostasis, 14(6), 1183-1191. https://doi.org/10.1111/jth.13329

Impact of incident myocardial infarction on the risk of venous thromboembolism: the Tromsø Study

You May Also Like